Physician Effectiveness in Interventions to Improve Cardiovascular Medication Adherence: A Systematic Review
Open Access
- 13 May 2010
- journal article
- review article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 25 (10) , 1090-1096
Abstract
Medications for the prevention and treatment of cardiovascular disease save lives but adherence is often inadequate. The optimal role for physicians in improving adherence remains unclear. Using existing evidence, we set the goal of evaluating the physician’s role in improving medication adherence. We conducted systematic searches of English-language peer-reviewed publications in MEDLINE and EMBASE from 1966 through 12/31/2008. We selected randomized controlled trials of interventions to improve adherence to medications used for preventing or treating cardiovascular disease or diabetes. Articles were classified as either (1) physician “active”—a physician participated in designing or implementing the intervention; (2) physician “passive”—physicians treating intervention group patients received patient adherence information while physicians treating controls did not; or (3) physicians noninvolved. We also identified studies in which healthcare professionals helped deliver the intervention. We did a meta-analysis of the studies involving healthcare professionals to determine aggregate Cohen’s D effect sizes (ES). We identified 6,550 articles; 168 were reviewed in full, 82 met inclusion criteria. The majority of all studies (88.9%) showed improved adherence. Physician noninvolved studies were more likely (35.0% of studies) to show a medium or large effect on adherence compared to physician-involved studies (31.3%). Among interventions requiring a healthcare professional, physician-noninvolved interventions were more effective (ES 0.47; 95% CI 0.38–0.56) than physician-involved interventions (ES 0.25; 95% CI 0.21–0.29; p < 0.001). Among physician-involved interventions, physician-passive interventions were marginally more effective (ES 0.29; 95% CI 0.22–0.36) than physician-active interventions (ES 0.23; 95% CI 0.17–0.28; p = 0.2). Adherence interventions utilizing non-physician healthcare professionals are effective in improving cardiovascular medication adherence, but further study is needed to identify the optimal role for physicians.Keywords
This publication has 91 references indexed in Scilit:
- Increased Persistency in Medication Use by U.S. Medicare Beneficiaries With Diabetes Is Associated With Lower Hospitalization Rates and Cost SavingsDiabetes Care, 2009
- A Randomized Controlled Trial of Team-Based Care: Impact of Physician-Pharmacist Collaboration on Uncontrolled HypertensionJournal of General Internal Medicine, 2008
- Take Control of Your Blood pressure (TCYB) study: A multifactorial tailored behavioral and educational intervention for achieving blood pressure controlPatient Education and Counseling, 2008
- Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trialBMJ, 2007
- Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once‐daily atorvastatinPharmacoepidemiology and Drug Safety, 2005
- Adherence to MedicationNew England Journal of Medicine, 2005
- Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled studyJournal of Cardiac Failure, 2003
- Impact of an Electronic Medication Compliance Aid on Long‐Term Blood Pressure ControlThe Journal of Clinical Pharmacology, 1992
- Usefulness of a systemic hypertension in-hospital educational programThe American Journal of Cardiology, 1990
- Clinical effectiveness and cost-effectiveness of monitoring blood pressure of hypertensive employees at work.Hypertension, 1983